Performance analysis of Mangoceuticals (MGRX)
Annual Return
Over the past 3 years, MGRX has had an average annual return of -73.36%, underperforming the benchmark SPY, which returned +19.31% annual.
Since Mar 21, 2023, MGRX has had an average annual return of -77.42%, underperforming the benchmark SPY, which returned +21.95% annual.
| 2026 | 2025 | 2024 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.09% | -69.48% | -41.76% | -93.08% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -51.22% | +48.33% | -32.58% | -5.00% | +26.32% | -12.50% | +11.11% | -43.09% | |||||
| 2025 | +25.06% | +36.51% | -52.76% | -14.77% | +31.05% | -30.30% | +10.67% | +40.36% | -7.12% | -4.93% | -46.69% | -33.51% | -69.48% |
| 2024 | +30.49% | -37.10% | -4.58% | +12.18% | +61.84% | -22.76% | +31.58% | -40.00% | -1.67% | -33.05% | +5.57% | -3.36% | -41.76% |
| 2023 | -71.50% | -5.26% | +3.70% | +63.39% | -38.25% | +9.73% | -31.42% | -25.92% | +17.33% | -62.55% | -93.08% |
Drawdown analysis of Mangoceuticals (MGRX)
The maximum drawdown for the MGRX was -99.73%, occurring on Mar 20, 2026. This drawdown has not yet recovered.
The current MGRX drawdown is -99.30%.
Since Mar 21, 2023 MGRX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.73% | Mar 21, 2023 | 752 | Mar 20, 2026 | Ongoing | Ongoing | Ongoing |